Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment.
Lv J, Jiang Z, Yuan J, Zhuang M, Guan X, Liu H, Yin Y, Ma Y, Liu Z, Wang H, Wang X.
Lv J, et al. Among authors: liu z, liu h.
Front Immunol. 2023 Mar 16;14:1093716. doi: 10.3389/fimmu.2023.1093716. eCollection 2023.
Front Immunol. 2023.
PMID: 37006239
Free PMC article.